The Trump administration's recent strategy to impose tariffs on pharmaceutical imports, particularly from Canada, Mexico, and China, aims to rejuvenate domestic drug manufacturing by incentivizing companies to relocate their production operations back to the United States. This significant policy
In the realm of pharmaceutical production, ensuring the safety and efficacy of Active Pharmaceutical Ingredients (APIs) is paramount. However, with increasing regulatory scrutiny, supply chain challenges, and the complexities associated with modern drug formulations, the industry faces significant
Honeywell has unveiled a transformative technology named Digital Holographic Microscopy, integrating artificial intelligence (AI) to revolutionize the counting and classification of minute particles or cells. This innovative technique is poised to make a substantial impact across various
The Contract Development and Manufacturing Organization (CDMO) sector is undergoing a remarkable transformation as a result of significant geopolitical shifts in 2024. These transformations are exerting considerable influence on supply chain dynamics, regulatory landscapes, and market strategies,
Continuous Manufacturing (CM) is revolutionizing the pharmaceutical industry, particularly in the production of biologics. This article explores the advancements and advantages of CM, focusing on the concept of Fully Connected Continuous Manufacturing (FCCM) and its impact on biologics production,
The pharmaceutical industry's research and development (R&D) landscape is undergoing a significant transformation as artificial intelligence (AI) and machine learning (ML) infiltrate its traditionally hands-on processes. Time-consuming procedures involving controlled environments, manual labor, and
